296 related articles for article (PubMed ID: 38651153)
1. The research progress on radiation resistance of cervical cancer.
Liang M; Sheng L; Ke Y; Wu Z
Front Oncol; 2024; 14():1380448. PubMed ID: 38651153
[TBL] [Abstract][Full Text] [Related]
2. A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer.
Eksteen C; Riedemann J; Rass AM; Plessis MD; Botha MH; van der Merwe FH; Engelbrecht AM
Cancer Control; 2024; 31():10732748241261539. PubMed ID: 38881031
[TBL] [Abstract][Full Text] [Related]
3. Research progress in MCM family: Focus on the tumor treatment resistance.
Tian Y; Zhou Y; Chen F; Qian S; Hu X; Zhang B; Liu Q
Biomed Pharmacother; 2024 Apr; 173():116408. PubMed ID: 38479176
[TBL] [Abstract][Full Text] [Related]
4. Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance.
Zhou J; Lei N; Tian W; Guo R; Chen M; Qiu L; Wu F; Li Y; Chang L
Front Oncol; 2022; 12():999643. PubMed ID: 36313645
[TBL] [Abstract][Full Text] [Related]
5. Review of possible mechanisms of radiotherapy resistance in cervical cancer.
Zhang H; Wang X; Ma Y; Zhang Q; Liu R; Luo H; Wang Z
Front Oncol; 2023; 13():1164985. PubMed ID: 37692844
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Ubiquitin-Specific Protease 53 Enhances the Radiosensitivity of Human Cervical Squamous Cell Carcinoma by Regulating DNA Damage-Binding Protein 2.
Zhou Q; Yao X; Wu C; Chen S; Fan D
Technol Cancer Res Treat; 2020; 19():1533033820929792. PubMed ID: 32508265
[TBL] [Abstract][Full Text] [Related]
7. Breaking the DNA damage response to improve cervical cancer treatment.
Wieringa HW; van der Zee AG; de Vries EG; van Vugt MA
Cancer Treat Rev; 2016 Jan; 42():30-40. PubMed ID: 26643553
[TBL] [Abstract][Full Text] [Related]
8. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
10. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
11. High expression of Kruppel-like factor 4 as a predictor of poor prognosis for cervical cancer patient response to radiotherapy.
Liu HX; Li N; Wei L; Zhou FX; Ma R; Xiao F; Zhang W; Zhang Y; Hui YP; Song H; Chen BL
Tumour Biol; 2017 Jun; 39(6):1010428317710225. PubMed ID: 28639905
[TBL] [Abstract][Full Text] [Related]
12. Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer.
Lecavalier-Barsoum M; Chaudary N; Han K; Koritzinsky M; Hill R; Milosevic M
Int J Cancer; 2018 Sep; 143(5):1017-1028. PubMed ID: 29417588
[TBL] [Abstract][Full Text] [Related]
13. High Expression of SOX2 and OCT4 Indicates Radiation Resistance and an Independent Negative Prognosis in Cervical Squamous Cell Carcinoma.
Shen L; Huang X; Xie X; Su J; Yuan J; Chen X
J Histochem Cytochem; 2014 Jul; 62(7):499-509. PubMed ID: 24710660
[TBL] [Abstract][Full Text] [Related]
14. Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer.
Thomas SN; Liao Z; Clark D; Chen Y; Samadani R; Mao L; Ann DK; Baulch JE; Shapiro P; Yang AJ
Proteomes; 2013 Sep; 1(2):87-108. PubMed ID: 24860738
[TBL] [Abstract][Full Text] [Related]
15. Genomic Profiling of Chinese Cervical Cancer Patients Reveals Prevalence of DNA Damage Repair Gene Alterations and Related Hypoxia Feature.
Wen H; Guo QH; Zhou XL; Wu XH; Li J
Front Oncol; 2021; 11():792003. PubMed ID: 35071000
[TBL] [Abstract][Full Text] [Related]
16. Factors and molecular mechanisms of radiation resistance in cancer cells.
Alamilla-Presuel JC; Burgos-Molina AM; González-Vidal A; Sendra-Portero F; Ruiz-Gómez MJ
Int J Radiat Biol; 2022; 98(8):1301-1315. PubMed ID: 35225732
[TBL] [Abstract][Full Text] [Related]
17. BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair.
Ni M; Li J; Zhao H; Xu F; Cheng J; Yu M; Ke G; Wu X
Oncogene; 2021 Apr; 40(15):2711-2724. PubMed ID: 33712705
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell RNA Sequencing Reveals Multiple Pathways and the Tumor Microenvironment Could Lead to Chemotherapy Resistance in Cervical Cancer.
Gu M; He T; Yuan Y; Duan S; Li X; Shen C
Front Oncol; 2021; 11():753386. PubMed ID: 34900703
[TBL] [Abstract][Full Text] [Related]
19. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
20. CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16).
Cibula D; Borčinová M; Kocian R; Feltl D; Argalacsova S; Dvorak P; Fischerová D; Dundr P; Jarkovsky J; Höschlová E; Slama J; Scambia G
Int J Gynecol Cancer; 2022 Sep; ():. PubMed ID: 36100282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
